Infection-source-specific Therapy
Infection-Source-Specific Therapy is a targeted antimicrobial strategy that belongs to the class of precision treatment approaches, distinguished by its focus on tailoring therapeutic interventions to the specific anatomical or pathological origin of an infection.
13
Publications
1.3K
Citations
59
Authors
38
Institutions
Publications per year
2017–2026
3
13
1–5 of 13
59
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 59
38
HCA Healthcare
Nashville, United States
2 h-index
21 publications
2.5K citations

Washington University in St. Louis
St Louis, United States
2 h-index
21 publications
2.5K citations
Harvard Pilgrim Health Care
Boston, United States
2 h-index
27 publications
7.2K citations
University of California, Irvine
Irvine, United States
2 h-index
24 publications
4.9K citations
Harvard University
Cambridge, United States
2 h-index
27 publications
7.2K citations
Texas A&M Health Science Center
College Station, United States
2 h-index
21 publications
2.5K citations

John H. Stroger, Jr. Hospital of Cook County
Chicago, United States
2 h-index
21 publications
2.5K citations
AstraZeneca (Sweden)
Södertälje, Sweden
1 h-index
1 publications
21 citations
1–8 of 38
NEJM · 2 publications · 790 citations
2
h-index
IDCP · 1 publications · 66 citations
1
h-index
1 publications · 21 citations
1
h-index
1 publications · 17 citations
1
h-index
CC · 1 publications · 146 citations
1
h-index
1–5